Advertisements


Nektar announces six abstracts accepted for ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Conatus announces three accepted abstracts for AASLD annual meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

Aduro announces four abstracts accepted for presentation at SITC meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Nektar announces FDA accepted NDA fro NKTR-181

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2018

Tyme Technologies announces five clinical abstracts at ASCO annual meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Nektar Therapeutics Q3 Earnings Outlook

Nektar Therapeutics (NASDAQ: NKTR) announces its next round of earnings this Wednesday, Nov. 7. Here is Benzinga's everything-that-matters guide for the Q3 earnings announcement. read more.....»»

Category: blogSource: benzingaNov 7th, 2018

Alliant Energy Announces Third Quarter 2018 Results And Increased Annual Common Stock Dividend Target By 6% For 2019

MADISON, Wis., Nov. 6, 2018 /PRNewswire/ --¬†Alliant Energy Corporation (NYSE:LNT) today announced U.S. generally accepted accounting principles (GAAP) and non-GAAP consolida.....»»

Category: earningsSource: benzingaNov 6th, 2018

CORRECTED: NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings

AMES, Iowa, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In a release issued und.....»»

Category: earningsSource: benzingaNov 2nd, 2018

Ovid Therapeutics announces Phase 2 STARS topline data accepted for presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Evoke Pharma announces Gimoti NDA accepted for review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

EMD Serono announces NDA resubmission for cladribine tablets accepted by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2018

Unlocked: NBJ announces 2018 Small Business Awards honorees

Their employee count may be small, but they have a big impact on Nashville's business community. The Nashville Business Journal is excited to announce our 2018 Small Business Awards honorees. To assemble our list of winners, we accepted nominations .....»»

Category: topSource: bizjournalsJul 2nd, 2018

Bristol-Myers" BLA for Opdivo Label Expansion Accepted by FDA

Bristol-Myers Squibb Company (BMY) announces that the FDA accepts its suppleme.....»»

Category: worldSource: nytJun 22nd, 2018

Stemline announces "positive" presentations of SL-801, SL-701 at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Novartis Announces Positive Data on Kisqali and Tasigna

Novartis (NVS) announces positive data on breast cancer drug Kisqali and oncology drug Tasigna at the ASCO. Novartis NVS presented posi.....»»

Category: dealsSource: nytJun 4th, 2018

Pfizer announces OS improvement in dacomitinib compared to gefitinib at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Agios Pharmaceuticals announces new data from ivosidenib Phase 1 study at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Technical Take: Nektar plunges after ASCO update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Nektar drops 28%, or $25.45, to $64.90 following ASCO update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Nektar Therapeutics Preliminary Results At ASCO Means A Strong Push Into Phase 3 Studies

Nektar Therapeutics Preliminary Results At ASCO Means A Strong Push Into Phase 3 Studies.....»»

Category: topSource: seekingalphaJun 4th, 2018

Zymeworks announces ZW25 clinical data presented at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2018